Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Tiffany Chen, PhD
Principal Scientist, Rubius Therapeutics
About the author:
As a starting scientist at Rubius Therapeutics, Tiffany helped build out the company’s platform. She develops the prototyping efforts of the company for therapeutic candidates and platform expansion. She is currently in the early discovery team leading a group with a focus on autoimmune disease.
Prior to joining Rubius Therapeutics, Tiffany earned a Ph.D. in Biological Engineering from MIT in the laboratory of K. Dane Wittrup, Ph.D., where she engineered therapeutic proteins for immune modulation. At MIT, Tiffany was part of the NIH/NIGMS Biotechnology Training Program and conducted her internship at Genentech with the Antibody Engineering Department.
She holds a B.S. in Biomedical Engineering from the University of Texas at Austin, where she worked in the laboratory of George Georgiou, Ph.D. with a research focus on engineering enzymes.
Posts by Tiffany Chen, PhD
Posted on October 9th, 2017 in Pharma R&D
Over the past two decades, significant progress has been made in the treatment of a range of autoimmune disorders and today thousands of patients enjoy an improved quality of life as a result. However, current therapeutic approaches (more…)